Latest innovative laboratory automation technology from GenScript is set to streamline maxi-scale plasmid purification, significantly reducing the manpower and time required to obtain high-quality, ...
Setting its sights on production and R&D expansions, GenScript’s biologics subsidiary ProBio notched its third fundraising round in less than two years. The CDMO’s $224 million raise will provide fuel ...
PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy ...
GenScript ProBio is the subsidiary of GenScript Biotech Corp. (HK.1548), building upon GenScript’s solid gene synthesis technology and deep expertise in the antibody, cell, and gene therapy fields, ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
Strategic investment reinforces Europe as a core pillar of GenScript's global R&Dand production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results